Core Viewpoint - The upcoming earnings report for CMS Energy is anticipated to show a quarterly earnings per share (EPS) of $0.67, reflecting a 1.5% increase year-over-year, with revenues expected to reach $1.69 billion, indicating a 5% growth compared to the previous year [1]. Earnings Projections - There has been a downward revision of 2.2% in the consensus EPS estimate over the last 30 days, indicating a collective reassessment by analysts of their initial forecasts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts project 'Operating revenue- NorthStar Clean Energy' to be $89.91 million, representing a 21.5% increase from the year-ago quarter [5]. - The forecast for 'Operating revenue- Gas utility' is $353.40 million, indicating a 15.1% increase year-over-year [5]. - The consensus estimate for 'Operating revenue- Electric utility' is $1.23 billion, reflecting a 0.7% increase from the previous year [5]. Net Income Projections - The projected 'Net income (loss)- NorthStar Clean Energy' is expected to reach $17.01 million, compared to $16.00 million from the year-ago period [6]. Stock Performance - CMS Energy shares have shown a return of +3.1% over the past month, slightly underperforming compared to the Zacks S&P 500 composite's +3.4% change [6].

Dave & Buster's (PLAY) shares soared 9.4% in the last trading session to close at $34.18. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 1.9% loss over the past four weeks.Shares of this Texas-based owner and operator of high-volume venues are likely to have trended upward because of the optimism surrounding the strategic execution of its “back to basics” strategy, solidifying long-term prospects. The notable improvements driven ...

Core Viewpoint - East West Bancorp (EWBC) is expected to report quarterly earnings of $2.23 per share, reflecting a 7.7% increase year-over-year, with revenues projected at $699.03 million, a 9.6% increase compared to the previous year [1]. Earnings Projections - Over the last 30 days, the consensus EPS estimate has been revised upward by 0.6%, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Analysis - Analysts predict a 'Net interest margin' of 3.3%, unchanged from the previous year [5]. - The 'Efficiency ratio' is estimated at 36.9%, slightly improved from 37.1% year-over-year [5]. - The 'Average Balance - Total interest-earning assets' is projected to be $73.10 billion, up from $68.05 billion a year ago [5]. Capital Ratios - The 'Tier 1 capital ratio' is expected to reach 14.6%, an increase from 13.7% in the same quarter last year [6]. - The 'Total capital ratio' is forecasted at 15.7%, up from 15.1% year-over-year [6]. - The 'Adjusted efficiency ratio' is estimated at 34.9%, compared to 34.3% in the same quarter last year [6]. Loan and Asset Projections - The 'Leverage ratio' is expected to be 10.8%, an increase from 10.4% year-over-year [7]. - 'Total nonaccrual loans' are projected at $161.04 million, down from $165.88 million a year ago [7]. - 'Total nonperforming assets' are estimated to be $199.69 million, slightly up from $196.28 million year-over-year [7]. Income Forecasts - 'Net Interest Income' is projected to be $609.92 million, compared to $553.23 million in the same quarter last year [8]. - 'Total Noninterest Income' is expected to reach $90.39 million, up from $84.67 million year-over-year [8]. - 'Commercial and consumer deposit-related fees' are forecasted at $27.44 million, compared to $25.65 million in the same quarter last year [9]. Stock Performance - Shares of East West Bancorp have increased by 14.6% over the past month, outperforming the Zacks S&P 500 composite, which rose by 5.4% [9].

Company Overview - Vertex (VERX) shares increased by 5% to close at $36.21, following a notable trading volume that exceeded typical levels, contrasting with a 6.6% loss over the past four weeks [1] - The company is benefiting from the rising adoption of e-invoicing mandates and cloud migration within the enterprise sector [1] Earnings Expectations - Vertex is projected to report quarterly earnings of $0.14 per share, reflecting a year-over-year decline of 6.7%, while revenues are expected to reach $184.25 million, marking a 14.4% increase from the previous year [2] - The consensus EPS estimate for Vertex has been revised 3% lower in the last 30 days, indicating a negative trend in earnings estimate revisions, which typically does not lead to price appreciation [3] Industry Context - Vertex operates within the Zacks Internet - Software industry, where another company, Exodus Movement, Inc. (EXOD), saw its stock rise by 2.1% to $33.7, with a 5.2% return over the past month [3] - Exodus Movement, Inc. has an unchanged consensus EPS estimate of -$0.17, representing a 54.1% improvement from the previous year, but currently holds a Zacks Rank of 5 (Strong Sell) [4]

Core Viewpoint - Analysts project Texas Capital (TCBI) will report quarterly earnings of $1.28 per share, a 60% increase year over year, with revenues expected to reach $298.24 million, an 11.7% increase from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 0.7% in the past 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Financial Metrics - Analysts estimate the 'Efficiency Ratio' to be 66.6%, down from 70.6% a year ago [4]. - The 'Net Interest Margin' is expected to be 3.2%, up from 3.0% in the same quarter last year [5]. - The 'Average Balance - Total earning assets' is projected at $30.98 billion, compared to $28.57 billion a year ago [5]. - 'Total Non-Performing Assets' are estimated at $96.88 million, up from $85.02 million a year ago [5][6]. Income Projections - 'Net Interest Income' is forecasted to reach $245.58 million, compared to $216.58 million last year [6]. - 'Total Non-Interest Income' is expected to be $52.56 million, up from $50.42 million a year ago [6]. - 'Net Interest Income (FTE)' is estimated at $246.85 million, compared to $216.65 million in the same quarter last year [7]. - 'Wealth Management and Trust Fee Income' is projected at $4.02 million, up from $3.70 million last year [7]. Additional Income Metrics - 'Service Charges on Deposit Accounts' are expected to reach $8.12 million, compared to $5.91 million a year ago [8]. - 'Other Non-Interest Income' is projected at $8.22 million, up from $7.99 million last year [8]. - 'Trading Income' is expected to be $6.12 million, compared to $5.65 million in the same quarter last year [9]. Stock Performance - Texas Capital shares have returned +14.6% over the past month, outperforming the Zacks S&P 500 composite's +4% change [9].

Core Viewpoint - Progressive (PGR) is expected to report significant growth in earnings and revenues for the upcoming quarter, with analysts predicting earnings of $4.30 per share, a 62.3% increase year-over-year, and revenues of $21.52 billion, reflecting a 17.9% increase [1]. Earnings Projections - The consensus EPS estimate has been revised 1.1% higher in the last 30 days, indicating a collective reevaluation by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue and Key Metrics - Analysts forecast 'Service revenues' at $128.06 million, a year-over-year increase of 20.5% [5]. - 'Net premiums earned' are expected to be $20.19 billion, reflecting a 17.3% increase from the prior year [5]. - 'Investment income' is projected to reach $860.70 million, indicating a year-over-year change of 25.7% [5]. Expense and Combined Ratios - 'Net premiums earned - Commercial Lines' are estimated at $2.78 billion, a 4.3% year-over-year change [6]. - The 'Companywide Total - Expense ratio' is projected at 19.7%, up from 19.0% in the same quarter last year [6]. - The 'Companywide Total - Combined ratio' is expected to be 88.7%, compared to 91.9% a year ago [6]. Loss Ratios - The 'Companywide Total - Loss/LAE ratio' is forecasted to be 68.9%, down from 72.9% in the previous year [7]. - The 'Property Business - Combined ratio' is expected to reach 107.3%, significantly improved from 166.3% in the same quarter last year [7]. Business Segment Insights - The 'Commercial Lines Business - Combined ratio' is estimated at 89.9%, slightly higher than the year-ago figure of 88.6% [8]. - The 'Property Business - Loss/LAE ratio' is projected to be 78.3%, down from 137.4% a year ago [8]. - The 'Property Business - Expense ratio' is expected to be 29.0%, compared to 28.9% in the previous year [8]. Stock Performance - Over the past month, Progressive shares have declined by 7.1%, contrasting with the S&P 500 composite's increase of 4.1% [9].

Company Overview - MiMedx (MDXG) shares increased by 8% in the last trading session, closing at $7, with higher trading volume compared to normal sessions [1] - The stock has shown a 0.5% gain over the past four weeks [1] - The rise in stock price is linked to investor optimism regarding the company's product portfolio in wound care, burn, and surgical sectors [1] Financial Performance - MiMedx is expected to report quarterly earnings of $0.06 per share, reflecting a year-over-year decline of 25% [2] - Revenue projections for the upcoming quarter are $89.28 million, which is a 2.4% increase from the same quarter last year [2] Earnings Estimates and Stock Movement - The consensus EPS estimate for MiMedx has remained unchanged over the last 30 days, indicating stability in earnings expectations [4] - Historical data suggests that stock prices typically do not continue to rise without trends in earnings estimate revisions [3][4] Industry Context - MiMedx operates within the Zacks Medical - Biomedical and Genetics industry, which includes other companies like PTC Therapeutics (PTCT) [5] - PTC Therapeutics has experienced a 0.7% decline in its stock price, with a return of -7.2% over the past month [5] - The consensus EPS estimate for PTC Therapeutics has decreased by 0.4% to -$1.07, representing a 7.8% increase from the previous year [6]

Core Viewpoint - Analysts expect Affirm Holdings (AFRM) to report a quarterly loss of $0.08 per share, reflecting an 81.4% year-over-year increase in losses, with revenues projected at $783.11 million, a 35.9% increase from the previous year [1]. Earnings Projections - There has been a 4.9% upward revision in the consensus EPS estimate over the last 30 days, indicating analysts' reassessment of their initial forecasts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts project 'Revenue- Merchant network' to reach $199.48 million, a 25.2% increase year-over-year [5]. - 'Revenue- Card network' is expected to be $46.40 million, reflecting a 30.1% year-over-year change [5]. - 'Revenue- Interest income' is forecasted at $414.44 million, indicating a 31.3% increase from the previous year [5]. - 'Revenue- Servicing income' is estimated at $31.25 million, suggesting a 23.5% year-over-year change [6]. - 'Revenue- Gain on sales of loans' is projected to reach $81.19 million, a significant 102.1% increase year-over-year [6]. - Gross Merchandise Volume (GMV) is expected to be $8,129.51 billion, up from $6,294 billion in the previous year [6]. Consumer Metrics - The average prediction for 'Transactions per Active Consumer' is 5, consistent with the same quarter of the previous year [7]. - Analysts estimate 'Active Consumers' to be 21, an increase from 18 reported in the same quarter last year [7]. Stock Performance - Over the past month, Affirm Holdings shares have gained 46.4%, significantly outperforming the Zacks S&P 500 composite, which saw a change of +0.4% [8]. - Affirm Holdings holds a Zacks Rank 1 (Strong Buy), indicating a likelihood of outperforming the overall market in the near future [8].

Core Viewpoint - Analysts project that Ametek (AME) will report quarterly earnings of $1.69 per share, reflecting a year-over-year increase of 3.1% and revenues of $1.74 billion, which is a 0.3% increase from the same quarter last year [1] Group 1: Earnings Projections - There has been a 0.1% upward revision in the consensus EPS estimate for the quarter over the last 30 days, indicating analysts' reassessment of their initial forecasts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Group 2: Key Metrics Estimates - Analysts estimate 'Net Sales- Electronic Instruments' to be $1.16 billion, representing a 0.2% increase year over year [5] - 'Net Sales- Electro mechanical' is projected to reach $581.78 million, indicating a 0.4% year-over-year change [5] - 'Operating Income- Electronic Instruments' is forecasted at $347.56 million, down from $352.94 million reported in the same quarter last year [6] - 'Operating Income- Electromechanical' is expected to be $122.95 million, up from $90.69 million in the previous year [6] Group 3: Stock Performance - Over the past month, Ametek shares have declined by 3.4%, compared to a 0.8% decrease in the Zacks S&P 500 composite [6] - Ametek holds a Zacks Rank 3 (Hold), suggesting its performance will likely align with the overall market in the near term [6]

Core Viewpoint - Analysts forecast Altria's quarterly earnings at $1.17 per share, reflecting a year-over-year increase of 1.7%, while revenues are expected to decline by 1.7% to $4.64 billion [1] Earnings Projections - The consensus EPS estimate has been adjusted downward by 1.9% over the past 30 days, indicating a reassessment by covering analysts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong link between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts estimate 'Net revenue- All Other/ Financial Services' at $36.00 million, representing an increase of 89.5% year-over-year [5] - 'Revenues net of excise taxes- Oral tobacco products' are projected at $633.90 million, showing a year-over-year change of 1.3% [5] - 'Revenues net of excise taxes- Smokeable Products' are expected to be $3.97 billion, reflecting a decline of 2.6% from the previous year [6] Operating Income - 'Operating Income (Loss)/ Reported OCI- Oral tobacco products' is estimated at $448.82 million, compared to $435 million reported in the same quarter last year [6] - 'Adjusted OCI- Smokeable Products' is predicted to reach $2.48 billion, slightly up from the year-ago value of $2.45 billion [7] Market Performance - Altria's shares have increased by 1.4% over the past month, contrasting with a decline of 5.1% in the Zacks S&P 500 composite [7] - With a Zacks Rank 4 (Sell), Altria is expected to underperform the overall market in the near future [7]